Offer - Urjas Oil for just ₹ 1 X
Gibtulio 25 Tablet is a prescription drug, available for use as Tablet. Diabetes Type 2 are some of its major therapeutic uses.
The right dosage of Gibtulio 25 Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Gibtulio 25 Tablet also has some side effects, the most common being Respiratory tract infection, Nausea or vomiting. Besides the aforementioned side effects, there are other adverse effects of Gibtulio 25 Tablet as well, which are listed below. Such side effects of Gibtulio 25 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Gibtulio 25 Tablet's effect during pregnancy is Severe and Moderate while nursing. In addition, Gibtulio 25 Tablet's effects on the liver, heart and kidney are discussed below in the Gibtulio 25 Tablet related warnings section.
Individuals suffering from medical conditions like Kidney Disease, Diabetes Type 1 must refrain from the use of Gibtulio 25 Tablet since this can cause severe adverse effects. Other contraindications of Gibtulio 25 Tablet have been discussed in the sections ahead.
Drug interactions for Gibtulio 25 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Gibtulio 25 Tablet, it is important to know that it is safe while driving, and is habit-forming.
Gibtulio 25 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Gibtulio 25 Tablet safe for pregnant women?
Gibtulio should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Gibtulio 25 Tablet safe during breastfeeding?
Gibtulio can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Gibtulio 25 Tablet on the Kidneys?
Gibtulio rarely affects the kidneys.
What is the effect of Gibtulio 25 Tablet on the Liver?
Using Gibtulio does not have any harmful effects on the liver.
What is the effect of Gibtulio 25 Tablet on the Heart?
Gibtulio has very mild side effects on the heart.
Gibtulio 25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Gibtulio 25 Tablet unless your doctor advises you to do so -
Is this Gibtulio 25 Tablet habit forming or addictive?
Gibtulio 25 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Gibtulio 25 Tablet does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Gibtulio 25 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Gibtulio 25 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Gibtulio 25 Tablet
It is safe to take Gibtulio 25 Tablet with food.
Interaction between Alcohol and Gibtulio 25 Tablet
Taking Gibtulio 25 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jardiance® (empagliflozin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 491-493